Gufic Biosciences Walk-In Interview Pithampur – Production Jobs | ITI, Diploma, B.Pharm | 17 January 2026
Company Overview
Gufic Biosciences Limited is a leading Indian pharmaceutical company specializing in injectable formulations. The company operates one of the world's largest lyophilized injectable plants in Indore.
Walk-In Interview Details
Date: Saturday, 17 January 2026
Time: 10:00 AM to 04:00 PM
Location: Gufic Biosciences Limited, Plot No. 48, Smart Industrial Park, Natrip, Pithampur, Dhar – 454775
Available Positions
1. Trainee Technician
Qualification: ITI (Fitter/Electrician) or Diploma (Mechanical/Pharmacy)
Experience: Freshers
Responsibilities: Vial/ampoule washing machines, filling & capping machines, batch manufacturing, autoclave, visual inspection
2. Junior Technician / Technician
Qualification: ITI, Diploma, D.Pharm
Experience: 2 to 10 Years
Responsibilities: Injectable production operations, batch manufacturing, filling, capping, autoclave handling, visual inspection
3. Officer / Senior Officer
Qualification: B.Pharm
Experience: 2 to 7 Years
Responsibilities: Batch manufacturing supervision, aseptic processing, lyophilization, QMS activities, deviation handling, CAPA
Important Notes
• Preference: Candidates with sterile pharma plant experience
• Immediate joiners highly preferred
• Candidates must be willing to work in injectable manufacturing
• No prior registration required
Documents Required
Updated Resume, Last 3 months salary slips, Appointment letter, Increment letter
Contact: hr.indore@guficbio.com
Why Gufic Biosciences?
• Reputed injectable pharmaceutical company
• Strong quality and regulatory compliance
• Exposure to sterile manufacturing
• Career growth in pharma manufacturing
Categories
- Artificial Intelligence (AI)
- Technology
- Business
- Education
- Science
- Lifestyle
- Healthcare
- Entertainment
- Politics
- Environment
- Travel
- Finance
- Automobile
- News
- Art
- Causes
- Crafts
- career
- Dance
- Drinks
- Film
- Fitness
- Food
- Games
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
Read More
Cement Tiles Market Summary Cement Tiles Market Share is projected to grow at a CAGR of 3.3% from 2025 to 2035. The market expansion reflects increasing adoption across industrial and commercial applications, alongside rising infrastructure investments and broader implementation across enterprise operations. Cement tiles are decorative building materials used in...
3D Concrete Printing Market is evolving as builders seek efficient methods to address labor shortages and rising construction costs. Automated concrete printing improves productivity while maintaining consistent quality. The technology supports customized construction with enhanced accuracy. Growing investments in infrastructure continue to fuel market demand. The 3D concrete printing...
Regional dynamics significantly shape the Peptide CDMO Market. North America leads with the highest concentration of peptide drug developers and mature CDMO infrastructure. The United States hosts major players with FDA-approved facilities supporting global commercial supply. Canada contributes through specialized research-focused manufacturing capabilities. Europe maintains a strong position,...
The China Animal Vaccines Market is witnessing healthy growth due to increasing demand for preventive veterinary healthcare across livestock and companion animals. Vaccines remain one of the most effective methods for protecting animals from infectious diseases, supporting productivity, and improving overall animal welfare. As China's livestock production and pet ownership continue to expand,...
Healthcare organizations are under increasing pressure to deliver exceptional patient care while managing complex regulatory requirements, rising operational costs, and evolving technology expectations. Over the past year, healthcare providers have accelerated digital transformation initiatives to improve collaboration, strengthen data security, and streamline administrative operations. As...
